Načítá se...
Zonisamide add‐on therapy for focal epilepsy
BACKGROUND: The majority of people with epilepsy have a good prognosis, and their seizures can be well controlled with the use of a single antiepileptic agent, but up to 30% develop refractory epilepsy, especially those with focal seizures. In this review, we summarised the evidence from randomised...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517010/ https://ncbi.nlm.nih.gov/pubmed/30335200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001416.pub4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|